Medscape November 5, 2024
TOPLINE:
Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic retinopathy since 2021, despite approval from the US Food and Drug Administration; traditional remote imaging methods for the detection of the eye disorder remain more prevalent.
METHODOLOGY:
- Researchers conducted the retrospective cohort study using the TriNetX federated database across 62 healthcare organizations in the United States to evaluate national trends in the AI-based detection of diabetic retinopathy.
- They examined the records of patients with diabetes from January 2019 to December 2023, with data analysis completed in May 2024.
- Usage rates of a Current Procedural Terminology code for AI-based screening were compared with those of traditional codes for remote eye imaging and imaging...
Today's Sponsors
Today's Sponsor